At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
LB LandBridge Co. LLC
Market Closed 02-20 16:00:00 EST
68.52
+1.62
+2.42%
盘后70.00
+1.48+2.16%
18:31 EST
High68.89Low65.25Vol538.32K
Open66.70D1 Closing66.90Amplitude5.44%
Mkt Cap5.24BTradable Cap3.73BTotal Shares76.43M
T/O36.53MT/O Rate0.99%Tradable Shares54.50M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Earning Preview: LandBridge Co. LLC Q4 revenue is expected to increase by N/A, and institutional views are mostly bullish
Earnings Agent  ·  02-18
Earning Preview: LandBridge Co. LLC Q4 revenue is expected to increase by N/A, and institutional views are mostly bullish
LB Pharmaceuticals management to meet with Piper Sandler
TIPRANKS  ·  02-19 23:46
LB Pharmaceuticals management to meet with Piper Sandler
LB Group Plans Plans Up to 2-Billion-Yuan Short-Term Bond Issue
MT Newswires Live  ·  02-12
LB Group Plans Plans Up to 2-Billion-Yuan Short-Term Bond Issue
LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire  ·  02-11
LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
LIXTE Biotechnology (NASDAQ: LIXT) Positions LB-100 to Expand Effectiveness of Standard Cancer Treatment
TIPRANKS  ·  02-10
LIXTE Biotechnology (NASDAQ: LIXT) Positions LB-100 to Expand Effectiveness of Standard Cancer Treatment
Press Release: LB Pharmaceuticals Announces $100.0 Million Private Placement
Dow Jones  ·  02-05
Press Release: LB Pharmaceuticals Announces $100.0 Million Private Placement
LB Pharmaceuticals Advances LB-102 Into Long-Term Phase 3 Safety Study for Schizophrenia
TIPRANKS  ·  01-28
LB Pharmaceuticals Advances LB-102 Into Long-Term Phase 3 Safety Study for Schizophrenia
Roth MKM Keeps Their Buy Rating on LB Pharmaceuticals, Inc. (LBRX)
TIPRANKS  ·  01-27
Roth MKM Keeps Their Buy Rating on LB Pharmaceuticals, Inc. (LBRX)
LB Pharmaceuticals Advances LB-102 Into Phase 3, Setting Up a Key Schizophrenia Catalyst for Investors
TIPRANKS  ·  01-24
LB Pharmaceuticals Advances LB-102 Into Phase 3, Setting Up a Key Schizophrenia Catalyst for Investors
Press Release: LandBridge Schedules Fourth Quarter and Fiscal Year 2025 Earnings Release and Conference Call
Dow Jones  ·  01-22
Press Release: LandBridge Schedules Fourth Quarter and Fiscal Year 2025 Earnings Release and Conference Call
LB Pharmaceuticals Appoints Minako Pazdera, J.D., Ph.D. as General Counsel
GlobeNewswire  ·  01-21
LB Pharmaceuticals Appoints Minako Pazdera, J.D., Ph.D. as General Counsel
LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire  ·  01-13
LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
Is LandBridge’s Ranch Deal, Debt Raise and Insider Buying Altering The Investment Case For LandBridge (LB)?
Simply Wall St.  ·  01-09
Is LandBridge’s Ranch Deal, Debt Raise and Insider Buying Altering The Investment Case For LandBridge (LB)?
Roth Capital Initiates Coverage on LB Pharmaceuticals With Buy Rating
MT Newswires Live  ·  01-09
Roth Capital Initiates Coverage on LB Pharmaceuticals With Buy Rating
LB Pharmaceuticals initiated with a Buy at Roth Capital
TIPRANKS  ·  01-09
LB Pharmaceuticals initiated with a Buy at Roth Capital
LB Pharmaceuticals, Inc. (LBRX) Receives a New Rating from Roth MKM
TIPRANKS  ·  01-09
LB Pharmaceuticals, Inc. (LBRX) Receives a New Rating from Roth MKM
Officer Bolling Harrison Fenner Acquires Common Shares of LandBridge Company LLC
Reuters  ·  01-07
Officer Bolling Harrison Fenner Acquires Common Shares of LandBridge Company LLC
Press Release: LB Pharmaceuticals Strengthens Leadership Team with Key Appointments in Corporate Affairs and People & Culture
Dow Jones  ·  01-06
Press Release: LB Pharmaceuticals Strengthens Leadership Team with Key Appointments in Corporate Affairs and People & Culture
LB Group to Boost Capital, Introduce New Investors to Subsidiary
MT Newswires Live  ·  2025-12-30
LB Group to Boost Capital, Introduce New Investors to Subsidiary
LB's Unit to Add Share in Partnership Fund for 63 Million Yuan
MT Newswires Live  ·  2025-12-30
LB's Unit to Add Share in Partnership Fund for 63 Million Yuan

Introduction

Company Name.
LandBridge Co. LLC
Affiliated Markets:
NYSE
Listing Date:
--
Main Business:
L Brands, Inc. operates as a specialty retailers of body care, home fragrance products, soaps, and sanitizers. The company sells its products under the Bath & Body Works, White Barn, C.O. Bigelow, and other brand names. It operates approximately 1,750 Bath & Body Works stores in the United States and Canada, as well as online at BathandBodyWorks.com. In addition, the company has approximately 295 stores in 30 other countries operating under franchise, license, and wholesale arrangements. L Brands, Inc. was founded in 1963 and is headquartered in Columbus, Ohio.
Issue price:
--